Keyes Stange & Wooten Wealth Management’s Daxor DXR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-15,914
Closed -$156K 75
2025
Q2
$156K Hold
15,914
0.08% 71
2025
Q1
$129K Buy
15,914
+1,302
+9% +$10.2K 0.07% 66
2024
Q4
$112K Hold
14,612
0.07% 69
2024
Q3
$126K Buy
14,612
+3,771
+35% +$33.7K 0.08% 68
2024
Q2
$101K Hold
10,841
0.07% 67
2024
Q1
$96.4K Buy
+10,841
New +$93.8K 0.08% 63

Other funds holding DXR

Keyes Stange & Wooten Wealth Management's DXR Position: Q3 2025 in Review

Keyes Stange & Wooten Wealth Management sold out of Daxor (DXR) in Q3 2025, closing a stake of 15,914 shares — an estimated $156K sold.

Keyes Stange & Wooten Wealth Management first reported a position in DXR in Q1 2024 and held it in 6 quarters. The position peaked at $156K in Q2 2025. 6 funds tracked by Wall St. Rank hold DXR as of Q3 2025.

  • Keyes Stange & Wooten Wealth Management reported no remaining Daxor position as of Q3 2025 after selling out during the quarter.
  • Keyes Stange & Wooten Wealth Management sold 15,914 Daxor shares in Q3 2025, an estimated $156K.
  • Keyes Stange & Wooten Wealth Management first reported a position in Daxor in Q1 2024 and held it in 6 quarters.
  • Keyes Stange & Wooten Wealth Management's Daxor position peaked at $156K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Daxor as of Q3 2025.

Based on Keyes Stange & Wooten Wealth Management's 13F filing for Q3 2025, filed 25 Nov 2025.